News

Sjögren’s Foundation Awards Scientists for ‘Outstanding’ Work

The Sjögren’s Foundation has given it 2021 Outstanding Abstract Award to two scientists who presented new research about Sjögren’s syndrome at this year’s annual meeting of the American College of Rheumatology. The award “recognizes exceptional research and encourages investigators to continue to focus on Sjögren’s throughout their career,”…

Ianalumab, an Antibody, Eases Sjögren’s Symptoms at High Dose in Trial

Ianalumab (VAY736), an investigational antibody to treat Sjögren’s syndrome, at high dose was well-tolerated by patients using it for one year, and led to reductions in disease activity and significantly greater saliva production, data from a Phase 2b clinical trial show. Findings were shared at the 2021 American College of Rheumatology…

Loss of Smell Linked to Disease Severity

Sensitivity to smell is reduced in people with Sjögren’s syndrome, compared with healthy controls, and appears to be linked to the severity of the disease, a new study reports. The study, “Olfactory impairment in patients with primary Sjogren’s syndrome and its correlation with organ involvement and immunological abnormalities,”…

Registration Open for Virtual Sjögren’s Patient Conference

The Sjögren’s Foundation will host a one-day virtual conference aimed at increasing patients’ understanding and management of symptoms. The conference will feature Sjögren’s syndrome experts and the focus will be on the nervous system and Sjögren’s, according to a press release, Scheduled for noon to 4:30 p.m. EST on Nov. 13,…

New ICD-10 Codes in US, Specific for Sjögren’s Patients, in Effect

After a four-year effort led by the Sjögren’s Foundation, new health statistics codes in the U.S. — known as ICD-10 codes — recognizing Sjögren’s syndrome as a distinctive condition from “sicca” are now in effect. The codes are officially known as the International Statistical Classification of Diseases and…